← Evidence map

SynthesisInternational journal of clinical oncology2023

Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.

Kazuhiro Nishikawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer. | OpenQuestion